Unlock stock picks and a broker-level newsfeed that powers Wall Street.

ASX - Delayed Quote AUD

CurveBeam AI Limited (CVB.AX)

Compare
0.1000
+0.0050
+(5.26%)
At close: 11:25:23 AM GMT+10
Loading Chart for CVB.AX
  • Previous Close 0.0950
  • Open 0.1000
  • Bid 0.0950 x --
  • Ask 0.1000 x --
  • Day's Range 0.1000 - 0.1000
  • 52 Week Range 0.0850 - 0.2900
  • Volume 32,000
  • Avg. Volume 314,534
  • Market Cap (intraday) 39.027M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0500
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 0.18

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe and North America. The company builds artificial intelligence tools to aid in bone separation and segmentation, empowering orthopedic surgeons to make 3D-based deformity measurements to inform clinical decisions. It is also involved in AI's Deep Learning AI based platform aids in bone microstructure analysis. The company's target customers include orthopedic practices, imaging centers, and hospitals. CurveBeam AI Limited was incorporated in 2009 and is headquartered in Hatfield, Pennsylvania.

curvebeamai.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: CVB.AX

View More

Performance Overview: CVB.AX

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

CVB.AX
25.93%
S&P/ASX 200 [XJO] (^AXJO)
6.28%

1-Year Return

CVB.AX
47.37%
S&P/ASX 200 [XJO] (^AXJO)
2.14%

3-Year Return

CVB.AX
69.70%
S&P/ASX 200 [XJO] (^AXJO)
2.15%

5-Year Return

CVB.AX
69.70%
S&P/ASX 200 [XJO] (^AXJO)
41.94%

Compare To: CVB.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CVB.AX

View More

Valuation Measures

Annual
As of 4/11/2025
  • Market Cap

    39.03M

  • Enterprise Value

    46.40M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.31

  • Price/Book (mrq)

    0.96

  • Enterprise Value/Revenue

    5.79

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -246.09%

  • Return on Assets (ttm)

    -17.36%

  • Return on Equity (ttm)

    -44.36%

  • Revenue (ttm)

    7.91M

  • Net Income Avi to Common (ttm)

    -19.45M

  • Diluted EPS (ttm)

    -0.0500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.85M

  • Total Debt/Equity (mrq)

    39.77%

  • Levered Free Cash Flow (ttm)

    -11.61M

Research Analysis: CVB.AX

View More

Company Insights: CVB.AX

Research Reports: CVB.AX

View More

People Also Watch